UC San Francisco has named Laura Dannels, PhD, MBA, as its next chief human resources officer. She will serve as Associate ...

Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...

Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”), a clinical-stage biopharmaceutical company developing ...

Prayagraj: The Staff Selection Commission (SSC) has declared results for the recruitment examination for Multi-Tasking Staff ...

Louise Liu Named To Boston Business Journal's Prestigious 2025“40 Under 40” List. EINPresswire / -- The Boston Business Journal has announced its highly anticipated 2025“40 Under 40” honorees, recogni ...

A total of 683 BTech, 56 MTech, and 40 PhD degrees were conferred during the convocation with 667 students awarded in person ...

Sengupta Debjani Debdatta, MTech (Pharm) pharmaceutical technology and DivyaTrehan, MBA (Pharm) received the gold medals ...

Patiala: The Thapar Institute of Engineering & Technology (TIET) hosted its Convocation 2025 from October 15 to 17.The ...

Title: A phase 1 trial evaluating the safety, tolerability, PK, and preliminary efficacy of QTX3034, an oral G12D-preferring allosteric KRAS inhibitor, in patients with solid tumors with KRASG12D ...

Ficerafusp alfa is currently being evaluated in FORTIFI-HN01, a pivotal Phase 2/3 clinical trial in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma ...

How regulation can spark life-saving innovation. MHRA ForewordThe regulation of medicine must not be seen as an obstacle, but rather a catalyst for ...